Vaishali Sharma | Neuroscience Data Analysis | Best Researcher Award

Dr. Vaishali Sharma | Neuroscience Data Analysis | Best Researcher Award

Post Graduate Institue of Medical Education and Research (PGIMER) | India

Dr. Vaishali Sharma is a Senior Research Fellow at the Department of Neurology, Post Graduate Institute of Medical Education and Research (PGIMER), Chandigarh, specializing in neurobiology, neuroinflammation, and sleep disorders. She earned her Ph.D. in Neurology (2020–2025) from PGIMER, focusing on the role of aquaporins, heat shock proteins, and neuroinflammatory markers in idiopathic intracranial hypertension (IIH) and their correlation with clinical parameters. She also holds a master’s degree in Zoology and a bachelor’s in Medical Science. Her research encompasses molecular biomarkers, blood-brain barrier disruption, circadian rhythm disturbances, and the evaluation of sleep and headache disorders, combining clinical, translational, and systematic review approaches. Dr. Sharma has contributed to multiple peer-reviewed publications and conference presentations, investigating psychiatric and sleep abnormalities, migraine care, and IIH pathophysiology. She has been recognized with several awards and fellowships, including CSIR and ICMR travel grants, best poster awards, and national and international research fellowships. Her professional activities extend to academic leadership and organizing conferences in neuro-ophthalmology and neurology. Dr. Sharma’s work advances the understanding of neuroinflammatory mechanisms, sleep disorders, and headache pathophysiology, providing insights for improved diagnosis, treatment, and quality of life for patients with neurological disorders.

Profile : Google Scholar

Featured Publications

Choudhary, N., Kumar, A., Sharma, V., Kaur, K., Kharbanda, P. S., Baishya, J., et al. (2024). “Effectiveness of CBT for reducing depression and anxiety in people with epilepsy: A systematic review and meta-analysis of randomized controlled trials.” Epilepsy & Behavior, 151, 109608.

Sharma, V., Chakravarty, K., Ray, S., Lal, V., & Takkar, A., Kharbanda, P. (2021). “Evaluation of prevalence and severity of obstructive sleep apnea using overnight-polysomnography in patients with idiopathic intracranial hypertension.” Journal of the Neurological Sciences, 429.

Sharma, V., Chakravarty, K., & Ray, S. (2023). “Questionnaire-based evaluation of sleep abnormality in patients with primary headache disorder: A cross-sectional study from tertiary care centre.” Journal of the Neurological Sciences, 455.

Sharma, S. R. V., & Chakravarty, K. (2023). “Questionnaire-based assessment of sleep abnormalities in patients with migraine: A cross-sectional study with a comparison group.” Annals of Indian Academy of Neurology, 26, S186.

Sharma, A. T. K., Chakravarty, K., Lal, V., & Kharbanda, P. S., et al. (2022). “Sleep and headache characteristics in patients with idiopathic intracranial hypertension (IIH) – An observational study.” Annals of Indian Academy of Neurology, 25, S296–S297.

Lining Huang | Bioinformatics | Research Excellence Award

Mr. Lining Huang | Bioinformatics | Research Excellence Award

The Second Hospital of Hebei Medical University | China

Dr. Huang is a distinguished researcher and attending physician specializing in perioperative neuroscience, with a Ph.D. in anesthesiology from Hebei Medical University. His career has centered on elucidating the molecular pathways through which blood–brain barrier dysfunction contributes to neurocognitive decline in aging surgical populations. Integrating molecular biology, neuroimaging, immunology, and microbiome science, he has established a multidisciplinary research program that advances understanding of the vascular–immune mechanisms driving perioperative neurocognitive disorders. From anesthesia-induced neurotoxicity in early studies to complex “vascular-immune–microbiome” interactions in recent work, his contributions span preclinical models, translational investigations, and clinical cohort studies. He has served as principal investigator on more than ten major funded projects, including multiple National Natural Science Foundation of China grants, and has earned notable distinctions such as the Hebei Province Science and Technology Progress Award and several first-prize Hebei Medical Science Awards. His commitment to academic scholarship includes translating Miller’s Anesthesia, editing national textbooks, and co-authoring expert consensus guidelines that shape anesthesiology education and practice nationwide. With a portfolio of influential publications and six national patents in airway-management innovations, Dr. Huang continues to advance therapeutic development and scientific knowledge in surgical brain protection and perioperative cognitive health.

Profile : Scopus

Featured Publications

SPP1-mediated crosstalk between macrophages and fibroblasts promotes benign airway stenosis. (2025). Archives of Biochemistry and Biophysics.

Association between preoperative blood–brain barrier permeability and postoperative delirium in older patients undergoing cardiac surgery: a pilot study. (2025). Aging Clinical and Experimental Research.

Central neuropeptides as key modulators of astrocyte function in neurodegenerative and neuropsychiatric disorders. (2025).

Neonatal sevoflurane exposure disrupted fatty acids metabolism, leading to hypomyelination and neurological impairments. (2025). Biomedicine and Pharmacotherapy.

Jia Liang | Neuroscience Data Analysis | Best Researcher Award

Prof. Jia Liang | Neuroscience Data Analysis | Best Researcher Award

Jinzhou Medical University | China

Prof. Jia Liang, Ph.D., is a distinguished neuroscientist and professor-level senior experimentalist at the Life Science Institute of Jinzhou Medical University, China. With over a decade of focused research in the field of neurobiology, her scientific journey has been defined by groundbreaking contributions to the understanding of cerebral ischemic injury and neuroprotection. Her work is widely recognized both nationally and internationally, marked by a robust portfolio of funded research projects, prolific publications, and collaborative engagements in translational neuroscience.

Professional Profile

SCOPUS

Education

Prof. Liang began her academic pursuit with a Bachelor’s degree in Clinical Medicine from Jinzhou Medical College. She further specialized in Physiology with a Master’s degree from Liaoning Medical University. Demonstrating a deep commitment to neurological sciences, she later completed her Ph.D. in Neurobiology from Capital Medical University in Beijing, where she developed her foundational expertise in molecular and cellular mechanisms underlying stroke-related brain injury.

Experience

Her professional career commenced as an Assistant Experimentalist at the Central Laboratory of Jinzhou Medical University, where she quickly ascended the ranks to become a Senior Experimentalist and eventually a Professor-level Senior Experimentalist at the university’s Life Science Institute. She also broadened her international exposure during her post-doctoral fellowship at the Health Science Centre of the University of New Mexico in the United States, where she engaged in advanced neuroscience research. Throughout her tenure, Prof. Liang has been deeply involved in mentoring students, managing laboratory operations, and leading numerous high-impact research projects on stroke and neural injury.

Research Interest

Prof. Liang’s primary research interests lie in the molecular mechanisms of brain injury and neuroprotection, especially within the context of cerebral ischemia. Her work explores the role of zinc in brain-to-spleen immune pathways, blood-brain barrier integrity, autophagy, ferroptosis, and the application of stem cell-derived exosomes in stroke therapy. A key focus of her research is understanding the neurovascular unit’s dynamics and identifying new biomarkers and therapeutic targets for ischemic injury. Her innovative use of nanotechnology, exosome biology, and targeted gene/protein modulation has significantly contributed to modern stroke therapeutics and regenerative neurology.

Award and Funding

Prof. Liang has received consistent research funding from prestigious sources, including the National Natural Science Foundation of China and the Natural Science Foundation of Liaoning Province.  She has also secured institutional and educational department grants focused on neuroprotection through mesenchymal stem cell-derived exosomes and the modulation of oxidative stress pathways. Her funding portfolio reflects both her scientific credibility and the practical relevance of her research in addressing pressing neurological health issues.

Publications

Brain Targeting Bacterial Extracellular Vesicles Enhance Ischemic Stroke Therapy via Efficient ROS Elimination and Suppression of Immune Infiltration
  • Authors: [Names not provided – please insert from source]

  • Journal: ACS Nano

  • Year: 2025

Indoleamine 2,3-dioxygenase-1 Involves in CD8⁺ T Cell Exhaustion in Glioblastoma via Regulating Tryptophan Levels
  • Authors: [Names not provided – please insert from source]

  • Journal: International Immunopharmacology

  • Year: 2024

β-1,4-Galactosyltransferase 1 Protects Against Cerebral Ischemia Injury in Mice by Suppressing Ferroptosis via the TAZ/Nrf2/HO-1 Signaling Pathway
  • Authors: [Names not provided – please insert from source]

  • Journal: CNS Neuroscience and Therapeutics

  • Year: 2024

Conclusion

Prof. Jia Liang stands at the forefront of experimental neurobiology with her comprehensive, multidisciplinary approach to stroke research. Her expertise spans molecular biology, immunology, stem cell therapy, and nanomedicine, allowing her to tackle complex neurovascular disorders with innovation and precision. With an extensive publication record in high-impact journals and an ever-expanding research network, she continues to influence the global neuroscience community through her discoveries, mentorship, and scientific leadership. Her future work promises to further unravel the intricacies of brain injury and recovery, ultimately paving the way for more effective treatments for stroke and related neurological conditions.